UCB - Ebit

Preço das Ações
239.00
Mudança Diária
-7.30 -2.96%
Mensal
-5.87%
Anual
59.65%
Q2 Previsão
233.96




Ebit Alterar Data
Alcon AG USD 317M 17M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Amarin USD -2.26M 564K 2025-12
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Galapagos EUR 780.56M 822.23M 2025-12
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 530M 2025-12
Orion EUR 114.8M 213.3M 2026-03
Recordati EUR 278.23M 112.58M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12
Unibail Rodamco EUR 844.1M 102.4M 2025-12